Clinical Trials
3
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Head and Neck CancerHead and Neck Cancer Stage IVHPV-Related Squamous Cell CarcinomaHPV-Related MalignancyHead and Neck CarcinomaHead and Neck Cancer Stage IIIHPV-Related CarcinomaHead and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- Ezra Cohen
- Target Recruit Count
- 15
- Registration Number
- NCT03795610
- Locations
- 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
Phase 1
Active, not recruiting
- Conditions
- Advanced Cancer
- Interventions
- Drug: personalized vaccine
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Ezra Cohen
- Target Recruit Count
- 30
- Registration Number
- NCT03568058
- Locations
- 🇺🇸
UCSD Medical Center, San Diego, California, United States
SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes
Phase 2
Terminated
- Conditions
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- Ezra Cohen
- Target Recruit Count
- 1
- Registration Number
- NCT02644122
- Locations
- 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
News
No news found